Effects of alkylxanthines and calcium antagonists on adenosine uptake by cultured rabbit coronary microvascular endothelium.
Adenosine uptake by cultured rabbit coronary microvascular endothelial cells was studied. Radiolabeled [2-3H]-adenosine, present initially in the extracellular space at 10(-6) mol/l, was incorporated into the cell cultures at a steady rate during 30 s-3 h incubations. Incorporated 3H was found mostly (83%) in adenine nucleotides. Incorporation of [3H]-adenosine was attenuated by an adenosine deaminase inhibitor (EHNA) but only at adenosine concentrations of 10(-5) mol/l or higher. Adenosine transport inhibitors (dipyridamole, nitrobenzylthioinosine) attenuated 3H incorporation. Adenosine uptake was also diminished by certain structural analogues of adenosine (e.g., 2-chloroadenosine), by several alkylxanthine drugs (theophylline, isobutylmethylxanthine, enprofylline and 8-phenyltheophylline), and by certain calcium antagonists (verapamil, nifedipine and trifluoperazine). The mechanisms of actions of these agents on adenosine uptake do not appear to be related to phosphodiesterase inhibition, adenosine receptor antagonism or calcium antagonism. The effects of varying adenosine metabolism may contribute to the pharmacologic actions of these agents.
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology*; D000225:Adenine / Q000031:analogs & derivatives / Q000494:pharmacology; D000241:Adenosine / Q000031:analogs & derivatives / Q000378:metabolism* / Q000494:pharmacology; D019830:Adenosine-5'-(N-ethylcarboxamide); D000818:Animals; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D002478:Cells, Cultured; D003331:Coronary Vessels / Q000378:metabolism*; D004176:Dipyridamole / Q000494:pharmacology; D004727:Endothelium / Q000378:metabolism*; D000431:Ethanol / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008833:Microcirculation / Q000378:metabolism; D011817:Rabbits; D013806:Theophylline / Q000031:analogs & derivatives* / Q000494:pharmacology*; D014268:Trifluoperazine / Q000494:pharmacology; D014970:Xanthines / Q000494:pharmacology*
D002121:Calcium Channel Blockers; D014970:Xanthines; D014268:Trifluoperazine; D019830:Adenosine-5'-(N-ethylcarboxamide); D000431:Ethanol; C010192:9-(2-hydroxy-3-nonyl)adenine; D004176:Dipyridamole; D013806:Theophylline; C034347:enprofylline; D000225:Adenine; D000241:Adenosine; D007545:Isoproterenol; D015056:1-Methyl-3-isobutylxanthine